A new 24-month subgroup analysis looked at sustained clinical response in participants who received up to two doses of RBX2660 across age, sex, race, and number of prior CDI episodes Two post hoc analyses of RBX2660 reviewed physical, mental, and social health-related quality of life (HRQL) data from PUNCH™ CD3 clinical program An oral presentation … [Read more…]
Webcast today at 8:00 am Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s ability to slow CKD progression in patients with metabolic acidosis and chronic kidney disease (CKD). Primary Endpoint Analysis The VALOR-CKD trial did not meet … [Read more…]
PDUFA target action date is June 8, 2023 HEIDELBERG, Germany, and CAMBRIDGE, MA, USA–(BUSINESS WIRE)–#cyclasol–Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for CyclASol® (cyclosporine ophthalmic solution), a … [Read more…]
Multiple poster presentations at the 2022 Fall Clinical Dermatology Conference share this and other data supporting Castle’s suite of tests for skin cancer FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from UTILISE (Clinical Utility and Health Outcomes Study), a … [Read more…]
— Next Generation Psilocin Prodrug, EB-373, Nominated to Advances to IND-Enabling Studies — —First Generation EVM101 Program for Cancer Related Distress has been discontinued — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction … [Read more…]
GenNext Technologies Wins the $250,000 Grand Prize at the BioTools Innovator Capstone Event LOS ANGELES–(BUSINESS WIRE)–#diagnostics—BioTools Innovator, the first-ever accelerator focused on life science tools companies, announced today that GenNext Technologies is the grand prize winner of the BioTools Innovator 2022 Final competition. The winning company was determined by a live audience vote on Thursday, … [Read more…]
New solution to empower accurate interpretation of Next-Generation Sequencing data Expanded offerings to make personalized treatment options a reality in UAE and region ABU DHABI, United Arab Emirates–(BUSINESS WIRE)–#genomics–In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership … [Read more…]
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report third quarter ended September 30, 2022 financial results after the close on Monday, November 7, 2022. Following distribution of the earnings release … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global OTC Topical Drugs Market (2022 Edition) – Analysis By Drug Class, Indication, End User, Formulation, Distribution Channel, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)” report has been added to ResearchAndMarkets.com’s offering. According to a research report published in August 2022, the Global OTC Topical drugs market … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Medical Device Regulatory Affairs Market By Services, By Service Provider, By Types, By Indication: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The global Medical Device Regulatory Affairs Market was valued at $6,969.7 million in 2021, and is projected to reach $12,247.7 million by 2031, registering a … [Read more…]
